Keywords: کارسینوم داکتال در محل; Computer-aided detection; digital mammography; screening performance measures; ductal carcinoma in situ;
مقالات ISI کارسینوم داکتال در محل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم داکتال در محل; Intraductal papilloma; Incidental; Non-incidental; Ductal carcinoma in situ; Atypical ductal hyperplasia; Upgrade;
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Breast-conserving therapy; Multi-center study; Declarations of interest none;
Keywords: کارسینوم داکتال در محل; DCIS; ductal carcinoma in situ; ER; estrogen receptor; ERBB2; tyrosine receptor kinase 2; OR; odds ratio; PR; progesterone receptor;
Keywords: کارسینوم داکتال در محل; NACT; neoadjuvant chemotherapy; pCR; complete pathological response; HER2; human epidermalgrowth factor receptor-2; NCCN; National Comprehensive Cancer Network; LABC; locally advanced breast cancer; M&P; Miller&Payne; DCIS; ductal carcinoma in situ; ER; e
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Digital breast tomosynthesis; Synthesized mammography; 2D mammography; 3D mammography; Full-field digital mammography; Calcifications;
Keywords: کارسینوم داکتال در محل; BP; blood pressure; DCIS; ductal carcinoma in situ; HDA; hemispherical detector array; MRI; magnetic resonance imaging; PAI; photoacoustic imaging; US; ultrasonography; VBP; vessel branching point; Biomarker; Breast cancer; Photoacoustic imaging; Vasculat
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; digital mammography; convolution neural network; deep learning; computer vision;
Keywords: کارسینوم داکتال در محل; Breast cancer-related deaths; Breast cancer-specific survival; Ductal carcinoma in situ; Population-based study;
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Radiotherapy; Margins; Recurrence;
Keywords: کارسینوم داکتال در محل; APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
Keywords: کارسینوم داکتال در محل; AI; aromatase inhibitor; ASCO; American Society of Clinical Oncology; CDK4/6; cyclin-dependent kinase 4/6; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER; estrogen receptor; FDA; Food and Drug Administration; HER2; human epidermal growth f
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Guidelines; Invasive breast cancer; Positive resection margin rate; Reoperation rate;
Keywords: کارسینوم داکتال در محل; Encapsulated papillary carcinoma; Ductal carcinoma in situ; Intraductal papillary carcinoma; Human breast carcinoma; Myoepithelium;
Keywords: کارسینوم داکتال در محل; ARV-825 PubChem CID 92044400; BETd-246 PubChem CID 131698640; dBET1 PubChem CID 91799313; I-BET151 PubChem CID 52912189; I-BET762 PubChem CID 46943432; JQ1 PubChem CID 46907787; MS417 PubChem CID 59190723; OTX015 PubChem CID 9936746; THZ1 PubChem CID 7360
Keywords: کارسینوم داکتال در محل; MG; Mammography; US; Ultrasound; MRI; Magnetic Resonance Imaging; BI-RADS; Breast Imaging Reporting and Data System; BC; Breast Cancer; BRCA; Breast CAncer Antigen; CC; Cranio-Caudal; MLO; Medio-Lateral-Oblique; TNBC; Triple-Negative Breast Cancer; DCIS;
Keywords: کارسینوم داکتال در محل; Pathological mineralization; Raman microscopy; Multimodal imaging; Biogenic whitlockite; Dystrophic mineralization; Label-free nondestructive chemical imaging; MCs; microcalcifications; DCIS; ductal carcinoma in situ; SHG/IF; second harmonic generation mi
Keywords: کارسینوم داکتال در محل; DIA; digital image analysis; AI; artificial intelligence; H&E; hematoxylin and eosin; IHC; immunohistochemistry; ISH; in situ hybridization; DCIS; ductal carcinoma in situ; ER; estrogen receptor α; PR; progesterone receptor; HER2; human epidermal growth
Keywords: کارسینوم داکتال در محل; microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: کارسینوم داکتال در محل; ADH; atypical ductal hyperplasia; ALH; atypical lobular hyperplasia; DBT; digital breast tomosynthesis; DCIS; ductal carcinoma in situ; DM; digital two-dimensional mammography; FEA; flat epithelial atypia; HRL; high-risk lesion; LCIS; lobular carcinoma in
Keywords: کارسینوم داکتال در محل; Dimorphic cell; Ductal carcinoma in situ; Breast carcinoma;
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Local recurrence; Prognostic factors;
Keywords: کارسینوم داکتال در محل; Biopsia ganglio centinela; Cáncer de mama; Carcinoma ductal in situ; Sentinel lymph node; Breast cancer; Ductal carcinoma in situ;
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; DCIS; Breast cancer; Fatigue; Quality of life;
Keywords: کارسینوم داکتال در محل; Breast cancer; Ductal carcinoma in situ; Breast conserving surgery; Radiotherapy; Hormonal status; Prognostic factors;
Keywords: کارسینوم داکتال در محل; Breast cancer; Accelerated partial breast irradiation; Radiation therapy; Ductal carcinoma in situ;
Keywords: کارسینوم داکتال در محل; Carcinoma, intraductal, noninfiltrating; carcinoma, ductal, breast; mammography; breast carcinoma in situ; breast neoplasms; DCIS; ductal carcinoma in situ; ER; estrogen receptor; IDC; invasive ductal carcinoma; PR; progesterone receptor;
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Breast conserving surgery; Radiation therapy; Breast cancer; Local relapse;
Keywords: کارسینوم داکتال در محل; AD; architectural distortion; BI-RADS; Breast Imaging Reporting and Data System; CC; craniocaudal; CESM; contrast-enhanced spectral mammography; CI; confidence interval; DBT; digital breast tomosynthesis; DCIS; ductal carcinoma in situ; DE-CESM; dual-ener
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Sentinel lymph node biopsy; Breast-conserving surgery; Mastectomy; National cancer care guidelines;
Keywords: کارسینوم داکتال در محل; Breast cancer; ductal carcinoma in situ; digital mammogram; microcalcification; CAD;
Keywords: کارسینوم داکتال در محل; DCIS; Ductal carcinoma in situ; Decision-making; Patient experience; Information needs; Communication;
Keywords: کارسینوم داکتال در محل; DCIS; Ductal carcinoma in situ; Breast cancer; Risk prediction; Prognostic tools; Patient stratification;
Keywords: کارسینوم داکتال در محل; Breast cancer; Ductal carcinoma in situ; Specimen radiography; Breast-conserving therapy; Free surgical margin;
Keywords: کارسینوم داکتال در محل; Screening mammography; resident education; simulation; breast imaging; ACR; American College of Radiology; ALH; atypical lobular hyperplasia; BCSC; Breast Cancer Surveillance Consortium; BI-RADS; Breast Imaging Reporting and Data System; CAD; computer-aid
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Ductal carcinoma in situ with invasive components; Breast magnetic resonance imaging (MRI); Invasive breast cancer;
Keywords: کارسینوم داکتال در محل; 3D ABUS; 3 dimensional automated breast ultrasound system; ACR; American College of Radiology; BI-RADS; breast imaging reporting and data system; FFDM; full-field digital mammography; FFDSM; full-field digital screening mammography; HHUS; manual handheld
Keywords: کارسینوم داکتال در محل; ACE; angiotensin converting enzyme inhibitors; AI; aromatase inhibitors; BC; breast cancer; DCIS; ductal carcinoma in situ; CVD; cardiovascular disease; ESC; European society of cardiology; GLS; global longitudinal strain; HFpEF; heart failure with preser
Keywords: کارسینوم داکتال در محل; Protease; Live-cell imaging; Breast cancer; Tumor microenvironment; 3D models; ABPs; activity-based probes; CAFs; carcinoma-associated fibroblasts; DCIS; ductal carcinoma in situ; DQ; dye quenched; ECM; extracellular matrix; FRET; fluorescence resonance e
Keywords: کارسینوم داکتال در محل; Mama; Carcinoma ductal in situ; Predicción de invasión; Breast; Ductal carcinoma in situ; Prediction of invasion;
Keywords: کارسینوم داکتال در محل; MI; microcalcification; B-US; DU; MI; Micropure Imaging; B-US; B-mode ultrasonography; DU; Doppler ultrasonography; AUC; area under the curve; DCIS; ductal carcinoma in situ; CDFI; color Doppler flow imaging; SD; spectral Doppler; RI; resistance index; NS
Keywords: کارسینوم داکتال در محل; Breast cancer; Tumor microenvironment; Extracellular matrix; Tumor stroma component; ECM-related signatures; ER; estrogen receptor; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; FEC; 5-fluorouracil+doxorubicin+cyclophosphamide; NKI; Neth
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Breast; Ultrasonography; Mammography; Histopathology;
Keywords: کارسینوم داکتال در محل; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; TDLU; terminal ductal lobular unit; Breast; Estrogens; Androgens; Tissue; Cancerous; Benign;
Keywords: کارسینوم داکتال در محل; Ductal carcinoma in situ; Ultrasound; Core needle biopsy;
Keywords: کارسینوم داکتال در محل; Breast cancer; Lumpectomy; Surgical margin; Intraoperative evaluation; Imaging; Polarization; BCS; breast conserving surgery; RCM; reflectance confocal microscopy; OCM; optical coherence microscopy; ASCO; American Society of Clinical Oncologists; CAP; Col
Keywords: کارسینوم داکتال در محل; ADH; atypical ductal hyperplasia; AH; atypical hyperplasia; ALH; atypical lobular hyperplasia; BBD; benign breast disease; BI-RADS; Breast Imaging Reporting and Data System; BSIP; benign solitary intraductal papilloma; CCL; columnar cell lesion; CNB; core
Keywords: کارسینوم داکتال در محل; lncRNA; long/large noncoding RNA; Xist; X-inactive specific transcript; mESC; mouse embryonic stem cell; Evf2; embryonic ventral forebrain 2; Six3os; sine oculis-related homeobox 3 homolog, opposite strand; Dlx1as; distal-less homeobox 1, antisense; EGO;
Keywords: کارسینوم داکتال در محل; Wide local excision; Breast cancer; Questionnaire; Margin; Ductal carcinoma in situ; DCIS;
Keywords: کارسینوم داکتال در محل; VVA; vulvovaginal atrophy; SERM; selective estrogen receptor modulator; NDA; new drug application; FDA; Food and Drug Administration; NSABP; National Surgical Adjuvant Breast & Bowel Project; STAR; Study of Tamoxifen and Raloxifene; ER; estrogen receptor;